- Country: Germany
- Summary: Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Golimumab (Atc Code: L04ab06).
- DET Ref No: 86075022
- Deadline: 28 Jul 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 444666-2023
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for medicinal products with the active substance golimumab (ATC code: L04AB06) within the period from October 1st, 2023 to September 30th, 2025 with the possibility of concluding the contract at any time during the term ("open-house model").
DocTitle: Antineoplastic and immunomodulating agents
Contract Type: Supplies - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINConclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Golimumab (Atc Code: L04ab06). - Germany Tender
The AOK LOWER SAXONY. THE HEALTH INSURANCE., a Government sector organization in Germany, has announced a new tender for Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Golimumab (Atc Code: L04ab06).. This tender is published on GermanyTenders under DET Ref No: 86075022 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-07-28.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
